FdaApplication
ANDA 216783
Identifiers
- fda_app_no: ANDA216783
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2024-10-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 500MG/2.5ML (200MG/ML) | SOLUTION;INTRAVENOUS |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 1GM/5ML (200MG/ML) | SOLUTION;INTRAVENOUS |
2 products